Relation of Serum Fetuin-A Levels to Coronary Artery Calcium in African-American Patients on Chronic Hemodialysis

American Journal of Cardiology

Volumn 103, Issue 1, 2009, Pages 46-49

  Zheng, Sijie ^a   de las Fuentes, Lisa ^b   Bierhals, Andrew ^c   Ash Bernal, Rachel ^b   Spence, Karen ^b   Slatopolsky, Eduardo ^a   Davila Roman, Victor G ^b   Delmez, James ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cardiovascular Imaging and Clinical Research Core Laboratory   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; FETUIN A; LIPID; PARATHYROID HORMONE; PHOSPHORUS; URIC ACID;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; AGED; BLOOD PROTEINS; CALCINOSIS; CALCIUM; CORONARY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MISSOURI; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149464873     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.032     Document Type: Article

References (26)

1. Collins A.J., Foley R., Herzog C., Chavers B., Gilbertson D., Ishani A., Kasiske B., Liu J., Mau L.W., McBean M., et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 51 (2008) S1-S320
2. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
3. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., and Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
4. Raggi P., Boulay A., Chasan-Taber S., Amin N., Dillon M., Burke S.K., and Chertow G.M. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 (2002) 695-701
5. Oh J., Wunsch R., Turzer M., Bahner M., Raggi P., Querfeld U., Mehls O., and Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106 (2002) 100-105
6. Guerin A.P., London G.M., Marchais S.J., and Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
7. Stompor T., Pasowicz M., Sullowicz W., Dembinska-Kiec A., Janda K., Wojcik K., Tracz W., Zdzienicka A., Klimeczek P., and Janusz-Grzybowska E. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41 (2003) 203-211
8. Block G.A., Spiegel D.M., Ehrlich J., Mehta R., Lindbergh J., Dreisbach A., and Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68 (2005) 1815-1824
9. Barreto D.V., Barreto F.C., Carvalho A.B., Cuppari L., Cendoroglo M., Draibe S.A., Moyses R.M., Neves K.R., Jorgetti V., Blair A., et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int 67 (2005) 1576-1582
10. Nitta K., Akiba T., Uchida K., Kawashima A., Yumura W., Kabaya T., and Nihei H. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42 (2003) 303-309
11. Moe S.M., Reslerova M., Ketteler M., O'Neill K., Duan D., Koczman J., Westenfeld R., Jahnen-Dechent W., and Chen N.X. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67 (2005) 2295-2304
12. Coen G., Manni M., Agnoli A., Balducci A., Dessi M., De Angelis S., Jankovic L., Mantella D., Morosetti M., Naticchia A., et al. Cardiac calcifications: fetuin-A and other risk factors in hemodialysis patients. ASAIO J 52 (2006) 150-156
13. Hermans M.M., Brandenburg V., Ketteler M., Kooman J.P., van der Sande F.M., Boeschoten E.W., Leunissen K.M., Krediet R.T., and Dekker F.W. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72 (2007) 202-207
14. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Bohm R., Metzger T., Wanner C., Jahnen-Dechent W., and Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361 (2003) 827-833
15. Stenvinkel P., Wang K., Qureshi A.R., Axelsson J., Pecoits-Filho R., Gao P., Barany P., Lindholm B., Jogestrand T., Heimburger O., et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67 (2005) 2383-2392
16. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (2003) S1-S201
17. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (2005) S1-S153
18. Wang A.Y., Woo J., Lam C.W., Wang M., Chan I.H., Gao P., Lui S.F., Li P.K., and Sanderson J.E. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20 (2005) 1676-1685
19. Honda H., Qureshi A.R., Heimburger O., Barany P., Wang K., Pecoits-Filho R., Stenvinkel P., and Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47 (2006) 139-148
20. Heiss A., DuChesne A., Denecke B., Grotzinger J., Yamamoto K., Renne T., and Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278 (2003) 13333-13341
21. Reynolds J.L., Skepper J.N., McNair R., Kasama T., Gupta K., Weissberg P.L., Jahnen-Dechent W., and Shanahan C.M. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16 (2005) 2920-2930
22. Szweras M., Liu D., Partridge E.A., Pawling J., Sukhu B., Clokie C., Jahnen-Dechent W., Tenenbaum H.C., Swallow C.J., Grynpas M.D., and Dennis J.W. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 277 (2002) 19991-19997
23. Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., Muller-Esterl W., Schinke T., and Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112 (2003) 357-366
24. Price P.A., and Lim J.E. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278 (2003) 22144-22152
25. Price P.A., Williamson M.K., Minh Thi Nguyen T., and Than T.N. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279 (2004) 1594-1600
26. Kronmal R.A., McClelland R.L., Detrano R., Shea S., Lima J.A., Cushman M., Bild D.E., and Burke G.L. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 115 (2007) 2722-2730